Global Rabies Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
According to APO Research, The global Rabies Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report presents an overview of global market for Rabies Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rabies Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Rabies Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rabies Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rabies Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rabies Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT and Hissen, etc.
Rabies Vaccine segment by Company
1. To analyze and research the global Rabies Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Rabies Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Rabies Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Rabies Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rabies Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rabies Vaccine industry.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Rabies Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Rabies Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report presents an overview of global market for Rabies Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rabies Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Rabies Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rabies Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rabies Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rabies Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT and Hissen, etc.
Rabies Vaccine segment by Company
- GSK (Novartis)
- Sanofi-Pasteur
- Chengda
- Yisheng
- Prcmise
- VACN
- Changsheng
- BCHT
- Hissen
- Vero Cell Rabies Vaccine
- BHK
- Chick Embryo Cell Rabies Vaccine
- Others
- Pre-exposure Prophylaxis
- Post-exposure Prophylaxis
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Rabies Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Rabies Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Rabies Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Rabies Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rabies Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rabies Vaccine industry.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Rabies Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Rabies Vaccine Sales Value (2019-2030)
1.2.2 Global Rabies Vaccine Sales Volume (2019-2030)
1.2.3 Global Rabies Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 RABIES VACCINE MARKET DYNAMICS
2.1 Rabies Vaccine Industry Trends
2.2 Rabies Vaccine Industry Drivers
2.3 Rabies Vaccine Industry Opportunities and Challenges
2.4 Rabies Vaccine Industry Restraints
3 RABIES VACCINE MARKET BY COMPANY
3.1 Global Rabies Vaccine Company Revenue Ranking in 2023
3.2 Global Rabies Vaccine Revenue by Company (2019-2024)
3.3 Global Rabies Vaccine Sales Volume by Company (2019-2024)
3.4 Global Rabies Vaccine Average Price by Company (2019-2024)
3.5 Global Rabies Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Rabies Vaccine Company Manufacturing Base & Headquarters
3.7 Global Rabies Vaccine Company, Product Type & Application
3.8 Global Rabies Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Rabies Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Rabies Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 RABIES VACCINE MARKET BY TYPE
4.1 Rabies Vaccine Type Introduction
4.1.1 Vero Cell Rabies Vaccine
4.1.2 BHK
4.1.3 Chick Embryo Cell Rabies Vaccine
4.1.4 Others
4.2 Global Rabies Vaccine Sales Volume by Type
4.2.1 Global Rabies Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Rabies Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Rabies Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Rabies Vaccine Sales Value by Type
4.3.1 Global Rabies Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Rabies Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Rabies Vaccine Sales Value Share by Type (2019-2030)
5 RABIES VACCINE MARKET BY APPLICATION
5.1 Rabies Vaccine Application Introduction
5.1.1 Pre-exposure Prophylaxis
5.1.2 Post-exposure Prophylaxis
5.2 Global Rabies Vaccine Sales Volume by Application
5.2.1 Global Rabies Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Rabies Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Rabies Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Rabies Vaccine Sales Value by Application
5.3.1 Global Rabies Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Rabies Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Rabies Vaccine Sales Value Share by Application (2019-2030)
6 RABIES VACCINE MARKET BY REGION
6.1 Global Rabies Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Rabies Vaccine Sales by Region (2019-2030)
6.2.1 Global Rabies Vaccine Sales by Region: 2019-2024
6.2.2 Global Rabies Vaccine Sales by Region (2025-2030)
6.3 Global Rabies Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Rabies Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Rabies Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Rabies Vaccine Sales Value by Region (2025-2030)
6.5 Global Rabies Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Rabies Vaccine Sales Value (2019-2030)
6.6.2 North America Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Rabies Vaccine Sales Value (2019-2030)
6.7.2 Europe Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Rabies Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Rabies Vaccine Sales Value (2019-2030)
6.9.2 Latin America Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Rabies Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
7 RABIES VACCINE MARKET BY COUNTRY
7.1 Global Rabies Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Rabies Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Rabies Vaccine Sales by Country (2019-2030)
7.3.1 Global Rabies Vaccine Sales by Country (2019-2024)
7.3.2 Global Rabies Vaccine Sales by Country (2025-2030)
7.4 Global Rabies Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Rabies Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Rabies Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 GSK (Novartis)
8.1.1 GSK (Novartis) Comapny Information
8.1.2 GSK (Novartis) Business Overview
8.1.3 GSK (Novartis) Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
8.1.5 GSK (Novartis) Recent Developments
8.2 Sanofi-Pasteur
8.2.1 Sanofi-Pasteur Comapny Information
8.2.2 Sanofi-Pasteur Business Overview
8.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
8.2.5 Sanofi-Pasteur Recent Developments
8.3 Chengda
8.3.1 Chengda Comapny Information
8.3.2 Chengda Business Overview
8.3.3 Chengda Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Chengda Rabies Vaccine Product Portfolio
8.3.5 Chengda Recent Developments
8.4 Yisheng
8.4.1 Yisheng Comapny Information
8.4.2 Yisheng Business Overview
8.4.3 Yisheng Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Yisheng Rabies Vaccine Product Portfolio
8.4.5 Yisheng Recent Developments
8.5 Prcmise
8.5.1 Prcmise Comapny Information
8.5.2 Prcmise Business Overview
8.5.3 Prcmise Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Prcmise Rabies Vaccine Product Portfolio
8.5.5 Prcmise Recent Developments
8.6 VACN
8.6.1 VACN Comapny Information
8.6.2 VACN Business Overview
8.6.3 VACN Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 VACN Rabies Vaccine Product Portfolio
8.6.5 VACN Recent Developments
8.7 Changsheng
8.7.1 Changsheng Comapny Information
8.7.2 Changsheng Business Overview
8.7.3 Changsheng Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Changsheng Rabies Vaccine Product Portfolio
8.7.5 Changsheng Recent Developments
8.8 BCHT
8.8.1 BCHT Comapny Information
8.8.2 BCHT Business Overview
8.8.3 BCHT Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 BCHT Rabies Vaccine Product Portfolio
8.8.5 BCHT Recent Developments
8.9 Hissen
8.9.1 Hissen Comapny Information
8.9.2 Hissen Business Overview
8.9.3 Hissen Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 Hissen Rabies Vaccine Product Portfolio
8.9.5 Hissen Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Rabies Vaccine Value Chain Analysis
9.1.1 Rabies Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Rabies Vaccine Sales Mode & Process
9.2 Rabies Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Rabies Vaccine Distributors
9.2.3 Rabies Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Rabies Vaccine Sales Value (2019-2030)
1.2.2 Global Rabies Vaccine Sales Volume (2019-2030)
1.2.3 Global Rabies Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 RABIES VACCINE MARKET DYNAMICS
2.1 Rabies Vaccine Industry Trends
2.2 Rabies Vaccine Industry Drivers
2.3 Rabies Vaccine Industry Opportunities and Challenges
2.4 Rabies Vaccine Industry Restraints
3 RABIES VACCINE MARKET BY COMPANY
3.1 Global Rabies Vaccine Company Revenue Ranking in 2023
3.2 Global Rabies Vaccine Revenue by Company (2019-2024)
3.3 Global Rabies Vaccine Sales Volume by Company (2019-2024)
3.4 Global Rabies Vaccine Average Price by Company (2019-2024)
3.5 Global Rabies Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Rabies Vaccine Company Manufacturing Base & Headquarters
3.7 Global Rabies Vaccine Company, Product Type & Application
3.8 Global Rabies Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Rabies Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Rabies Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 RABIES VACCINE MARKET BY TYPE
4.1 Rabies Vaccine Type Introduction
4.1.1 Vero Cell Rabies Vaccine
4.1.2 BHK
4.1.3 Chick Embryo Cell Rabies Vaccine
4.1.4 Others
4.2 Global Rabies Vaccine Sales Volume by Type
4.2.1 Global Rabies Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Rabies Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Rabies Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Rabies Vaccine Sales Value by Type
4.3.1 Global Rabies Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Rabies Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Rabies Vaccine Sales Value Share by Type (2019-2030)
5 RABIES VACCINE MARKET BY APPLICATION
5.1 Rabies Vaccine Application Introduction
5.1.1 Pre-exposure Prophylaxis
5.1.2 Post-exposure Prophylaxis
5.2 Global Rabies Vaccine Sales Volume by Application
5.2.1 Global Rabies Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Rabies Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Rabies Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Rabies Vaccine Sales Value by Application
5.3.1 Global Rabies Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Rabies Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Rabies Vaccine Sales Value Share by Application (2019-2030)
6 RABIES VACCINE MARKET BY REGION
6.1 Global Rabies Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Rabies Vaccine Sales by Region (2019-2030)
6.2.1 Global Rabies Vaccine Sales by Region: 2019-2024
6.2.2 Global Rabies Vaccine Sales by Region (2025-2030)
6.3 Global Rabies Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Rabies Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Rabies Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Rabies Vaccine Sales Value by Region (2025-2030)
6.5 Global Rabies Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Rabies Vaccine Sales Value (2019-2030)
6.6.2 North America Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Rabies Vaccine Sales Value (2019-2030)
6.7.2 Europe Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Rabies Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Rabies Vaccine Sales Value (2019-2030)
6.9.2 Latin America Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Rabies Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Rabies Vaccine Sales Value Share by Country, 2023 VS 2030
7 RABIES VACCINE MARKET BY COUNTRY
7.1 Global Rabies Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Rabies Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Rabies Vaccine Sales by Country (2019-2030)
7.3.1 Global Rabies Vaccine Sales by Country (2019-2024)
7.3.2 Global Rabies Vaccine Sales by Country (2025-2030)
7.4 Global Rabies Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Rabies Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Rabies Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Rabies Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Rabies Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Rabies Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 GSK (Novartis)
8.1.1 GSK (Novartis) Comapny Information
8.1.2 GSK (Novartis) Business Overview
8.1.3 GSK (Novartis) Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
8.1.5 GSK (Novartis) Recent Developments
8.2 Sanofi-Pasteur
8.2.1 Sanofi-Pasteur Comapny Information
8.2.2 Sanofi-Pasteur Business Overview
8.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
8.2.5 Sanofi-Pasteur Recent Developments
8.3 Chengda
8.3.1 Chengda Comapny Information
8.3.2 Chengda Business Overview
8.3.3 Chengda Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Chengda Rabies Vaccine Product Portfolio
8.3.5 Chengda Recent Developments
8.4 Yisheng
8.4.1 Yisheng Comapny Information
8.4.2 Yisheng Business Overview
8.4.3 Yisheng Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Yisheng Rabies Vaccine Product Portfolio
8.4.5 Yisheng Recent Developments
8.5 Prcmise
8.5.1 Prcmise Comapny Information
8.5.2 Prcmise Business Overview
8.5.3 Prcmise Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Prcmise Rabies Vaccine Product Portfolio
8.5.5 Prcmise Recent Developments
8.6 VACN
8.6.1 VACN Comapny Information
8.6.2 VACN Business Overview
8.6.3 VACN Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 VACN Rabies Vaccine Product Portfolio
8.6.5 VACN Recent Developments
8.7 Changsheng
8.7.1 Changsheng Comapny Information
8.7.2 Changsheng Business Overview
8.7.3 Changsheng Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Changsheng Rabies Vaccine Product Portfolio
8.7.5 Changsheng Recent Developments
8.8 BCHT
8.8.1 BCHT Comapny Information
8.8.2 BCHT Business Overview
8.8.3 BCHT Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 BCHT Rabies Vaccine Product Portfolio
8.8.5 BCHT Recent Developments
8.9 Hissen
8.9.1 Hissen Comapny Information
8.9.2 Hissen Business Overview
8.9.3 Hissen Rabies Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 Hissen Rabies Vaccine Product Portfolio
8.9.5 Hissen Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Rabies Vaccine Value Chain Analysis
9.1.1 Rabies Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Rabies Vaccine Sales Mode & Process
9.2 Rabies Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Rabies Vaccine Distributors
9.2.3 Rabies Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
